SUMO (small ubiquitin-related modifier) modification is known to have diverse effects on the activity of transcriptional regulators, often through alterations in their localization or interactions with other factors, and in most of the cases is associated with transcriptional repression. The DEAD-box family of RNA helicases includes a large number of proteins that are involved in various cellular processes. Several members are now known to be multifunctional and their activities are thought to be governed by interactions with other partners, which may be regulated by post-translational modifications. In the present paper, we shall briefly review recent evidence indicating that SUMO modification is important in modulating the activity of two DEAD-box proteins, p68 (Ddx5) and DP103 (Ddx20), which are known to be important transcriptional regulators.
Introduction
Members of the DEAD-box family of RNA helicases are characterized by nine conserved motifs, including the signature D-E-A-D sequence, and form a subgroup of the DEXD/H family of helicases [1] . These proteins have been highly conserved through evolution and are known to play key roles in all cellular processes that require manipulation of RNA structure, including transcription, RNA processing and export, and translation. Although initially thought to be largely processive RNA helicases, many are now thought to function more as RNA chaperones through local unwinding of RNA structures or remodelling of RNP (ribonucleoprotein) complexes. Moreover, several DEAD-box proteins have been found to act as transcriptional regulators and have been suggested to act as adaptor molecules between components of the transcriptional machinery [2] . SUMO (small ubiquitin-related modifier) modification of proteins is often associated with transcriptional repression [3] and in several cases this has been shown to be due to recruitment of transcriptional co-repressors, such as HDACs (histone deacetylases) [4, 5] . Recent reports have revealed two different mechanisms by which the DEAD-box proteins p68 and DP103 can repress transcription in a manner that is at least partly dependent on SUMOylation.
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helicase activity was demonstrated in vitro [7] . Although p68 has been shown to play a role in RNA processing [8, 9] , over the last few years there have been several reports indicating that p68 is also an important transcriptional regulator, acting both as a transcriptional co-activator for several transcription factors including ERα (oestrogen receptor α) [10] , the tumour suppressor p53 [11] and the myogenic regulatory factor MyoD [12] and, in some contexts, as a promoter-dependent transcriptional repressor [13] .
Our laboratory has recently demonstrated that p68 is SUMOylated in vivo on a single site (Lys-53) and that its SUMOylation was significantly enhanced by PIAS1 [protein inhibitor of activated STAT (signal transducer and activator of transcription) 1] [14] . Transcriptional repression by SUMOylation has been suggested to be mediated through HDAC recruitment for both the CRD1 (cell cycle regulatory domain 1) of p300 and the R motif repression domain of Elk1 [Ets (E twenty-six)-like kinase 1] [4, 5] . Therefore, since p68 interacts with HDAC1 and can act both as a transcriptional co-activator and a repressor [11, 13] , the idea that SUMOylation may in some way alter the balance of these activities, perhaps through modulation of interactions with other transcriptional co-activators and repressors, is very interesting. Our findings that a K53R mutant of p68 that is not SUMOylated does not co-immunoprecipitate with HDAC1 and is a better co-activator and a less efficient repressor [14] , are indeed consistent with SUMOylation favouring p68 acting as a transcriptional repressor, perhaps by modulating the balance of co-activator/co-repressor recruitment at the promoter (see Figure 1A) . Although our results indicate that p68 ubiquitination and SUMOylation are not mutually exclusive (F.V. Fuller-Pace, A.-M.F. Jacobs and S.M. Nicol, unpublished work), it will be very interesting to determine whether ubiquitination and indeed other modifications (e.g. phosphorylation) regulate the extent of p68 SUMOylation, providing an additional level of regulation to the modulation of p68 transcriptional co-activator/repressor activity.
DP103: indirect regulation of transcriptional suppression by SUMOylation
DP103 (Ddx20/Gemin3), like p68, is implicated in RNA processing [15] ; however, several studies have now demonstrated that it acts as a transcriptional suppressor/co-suppressor through interaction with other transcription factors and/or components of the transcription machinery. DP103 was found to form a co-repressor complex with METS [mitogenic Ets transcriptional suppressor], through recruitment of HDAC2 and HDAC5 [16] , and to repress transcriptional activation mediated by the EGR-2 (early growth response gene product 2)/Krox-20 transcription factor in a promoter-specific manner that is at least partly dependent on HDAC recruitment [17] . DP103 was also shown to repress the transcriptional activity of SF1 (steroidogenic factor 1) [18] . The potential role of SUMO modification was not examined in these studies; however, a later study on regulation of SF1 transcriptional activity by SUMOylation revealed an interesting mechanism by which DP103 represses transcription via SUMOylation [19] . This study [19] demonstrated that SUMO modification of SF1 repressed its transcriptional activity in an HDACindependent manner that involved direct interaction between SUMOylated SF1 and DP103. Interestingly, DP103 appeared to stimulate both PIAS-dependent SF1 SUMOylation and relocalization to discrete nuclear foci, suggesting that transcriptional repression of SF1 by DP103 is coupled with SUMOylation (see Figure 1B) , although it is not yet known whether DP103 is itself SUMOylated.
Conclusion/future directions
The idea that SUMO modification can affect the balance of transcriptional activation/repression activity of transcription factors, often through modulation of their interactions with co-activators/co-repressors, is well established. In the case of p68 and DP103, the mechanisms by which these are achieved are slightly different: p68 is itself directly SUMOylated, whereas DP103 interacts with SUMOylated SF1 to repress SF1 transcriptional activity.
It is also clear that SUMOylation may influence, or be influenced by, other post-translational modifications of target proteins. Therefore it will be interesting to examine whether other modifications add a further layer of complexity to the regulation of p68 and DP103 function by SUMOylation. Moreover, since p68 and DP103 are involved in multiple processes in the cell, SUMO modification may have more profound effects on their function, in terms of determining which cellular processes they participate in through influencing their choice of interacting partners. Future studies on these aspects could yield some intriguing results.
